George Kemble

Insider Reports History

Location
San Mateo, CA
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Kemble:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sagimet Biosciences Inc. Executive Chairman, Director Series A Common Stock 81,005 $623,268 $7.69 20 Nov 2025 Direct
Sagimet Biosciences Inc. Executive Chairman, Director Stock Option (Right to Buy) 32,250 09 Jun 2025 Direct

Insider Reports Filed by George Kemble

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGMT Sagimet Biosciences Inc. 20 Nov 2025 1 -$289,979 4 Executive Chairman, Director 21 Nov 2025, 18:13
SGMT Sagimet Biosciences Inc. 09 Jun 2025 1 $0 4 Director 10 Jun 2025, 17:40
SGMT Sagimet Biosciences Inc. 23 Jul 2024 1 -$74,830 4 Executive Chairman, Director 25 Jul 2024, 16:05
SGMT Sagimet Biosciences Inc. 19 Jul 2024 1 -$43,605 4 Executive Chairman, Director 23 Jul 2024, 16:05
SGMT Sagimet Biosciences Inc. 17 Nov 2023 1 $0 4 Executive Chairman, Director 21 Nov 2023, 16:22
SGMT Sagimet Biosciences Inc. 07 Sep 2023 2 +$4,448 4 Executive Chairman, Director 08 Sep 2023, 16:15
SGMT Sagimet Biosciences Inc. 18 Jul 2023 16 $0 4 Director 20 Jul 2023, 16:17
SGMT Sagimet Biosciences Inc. 13 Jul 2023 0 $0 3 Director 13 Jul 2023, 21:03